Healthcare

Moderna begins COVID-19 vaccine trials for children under 12

By Cassidy Morrison
Published March 16, 2021 2:08pm ET
Add Washington Examiner on Google
Moderna begins COVID-19 vaccine trials for children under 12
Moderna started clinical trials of its two-dose vaccine in children from six months to 11 years old in the United States and Canada, the company announced Tuesday. “This pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population,” Moderna CEO Stephane Bancel said. […]

Moderna started clinical trials of its two-dose vaccine in children from six months to 11 years old in the United States and Canada, the company announced Tuesday.

“This pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population,” Moderna CEO Stephane Bancel said.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

COVID-19 Vaccines